title: [The role of L-carnitine in nutritional status and echocardiographic parameters in idiopathic dilated cardiomyopathy in children].
abstract: OBJECTIVE
  Malnutrition is an independent predictor of death in idiopathic dilated cardiomyopathy. An analysis was performed of the impact of L-carnitine supplementation on the nutritional status and echocardiogram parameters of children with idiopathic dilated cardiomyopathy.
  
  
  METHODS
  This was an open label cohort of 11 patients who received L-carnitine (100 mg/kg/day) plus the conventional medical treatment, compared with 40 controls, matched for gender and age. The L-carnitine group was weighed 118 times and the controls 264 times. Additionally, the L-carnitine group underwent 65 two-dimensional echocardiograms and the controls 144. Chi-square, Student's t test, Person correlation and ANOVA were calculated with alpha = 0.05.
  
  
  RESULTS
  For the L-carnitine group: age at presentation = 3.82 years old, 72.7% (p = 0.033) were females younger than 2 years and 90.9% (p = 0.0001) were in functional classes III and IV. There were no deaths during this period. At presentation, no differences were observed in weight percentile (31.2+/-8.74 vs. 19.6+/-21.2) (p = 0.29) or z score (-0.68+/-1.05 vs. -1.16+/-0.89) (p = 0.24). Increases were observed in both the percentile (p = 0.026) and z score (p = 0.033) after the introduction of L-carnitine. At presentation, there were no differences in ejection fraction (54.9%+/-3.8 vs. 49.3%+/-6.6) (p = 0.19), but LV mass/BSA were greater in the L-carnitine group (169.12 g/m2+/-26.24 vs. 110.67 g/m2+/-15.62) (p = 0.0005). After the introduction of L-carnitine an increase in ejection fraction (48.3+/-7 to 67.2+/-7) (p = 0.044) was observed. LV mass/BSA decreased (164.29 g/m2+/-28.14 to 110.88 g/m2+/-28.88), but without significance (p = 0.089)
  
  
  CONCLUSIONS
  In children with idiopathic dilated cardiomyopathy, supplementation of L-carnitine may be helpful for nutritional and echocardiographic improvement.
authors.affiliation: Universidade do Estado do Rio de Janiero (UERJ), Instituto Nacional de Cardiologia Laranjeiras, Rio de Janeiro, RJ, Brazil. vitoraze@ig.com.br
authors.forename: Vitor M P
authors.initials: VM
authors.lastname: Azevedo
authors.forename: Francisco M
authors.initials: FM
authors.lastname: Albanesi Filho
authors.forename: Marco A
authors.initials: MA
authors.lastname: Santos
authors.forename: Márcia B
authors.initials: MB
authors.lastname: Castier
authors.forename: Maria Ourinda M
authors.initials: MO
authors.lastname: Cunha
mesh_terms: D000293:Adolescent; D002311:Cardiomyopathy, Dilated / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000503:physiopathology; D002331:Carnitine / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004812:Epidemiologic Methods; D005260:Female; D006352:Heart Ventricles / Q000000981:diagnostic imaging*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009200:Myocardial Contraction / Q000502:physiology; D009752:Nutritional Status / Q000502:physiology*; D013318:Stroke Volume / Q000502:physiology*; D013997:Time Factors; D014463:Ultrasonography; D014803:Vitamin B Complex / Q000627:therapeutic use*
chemical_list: D014803:Vitamin B Complex; D002331:Carnitine